Short-term Follow-up Recommendations after Preoperative Breast MR Assessment for Breast Cancer Diagnosis: Are We Lacking a Rational Basis?
R. James Brenner
Radiology 2010;257 18-21
Link to Journal
Unless clinical studies demonstrate previously unrecognized changes on serial MR imaging studies under such circumstances which likely are not based on the mechanisms of actions described earlier, the recommendation for short-term follow-up MR imaging after preoperative assessment should be reconsidered
Showing posts with label BIRADS 3. Show all posts
Showing posts with label BIRADS 3. Show all posts
Friday, 17 September 2010
Wednesday, 23 June 2010
Frequency of Malignancy Seen in Probably Benign Lesions at Contrast-enhanced Breast MR Imaging: Findings from ACRIN 6667
Frequency of Malignancy Seen in Probably Benign Lesions at Contrast-enhanced Breast MR Imaging: Findings from ACRIN 6667
Susan P. Weinstein, Lucy G. Hanna, Constantine Gatsonis, Mitchell D. Schnall, Mark A. Rosen, and Constance D. Lehman
Radiology 2010; 255 731-737
Link to Journal
In a multi-institutional study, the frequency of malignancy in MR-detected BI-RADS category 3 lesions was 0.9% (95% confidence interval: 0.02%, 5.14%)
Susan P. Weinstein, Lucy G. Hanna, Constantine Gatsonis, Mitchell D. Schnall, Mark A. Rosen, and Constance D. Lehman
Radiology 2010; 255 731-737
Link to Journal
In a multi-institutional study, the frequency of malignancy in MR-detected BI-RADS category 3 lesions was 0.9% (95% confidence interval: 0.02%, 5.14%)
Monday, 18 August 2008
BI-RADS 3, 4, and 5 Lesions: Value of US in Management--Follow-up and Outcome
BI-RADS 3, 4, and 5 Lesions: Value of US in Management--Follow-up and Outcome
Sughra Raza, Sona A. Chikarmane, Sarah S. Neilsen, Lisa M. Zorn, and Robyn L. Birdwell
Radiology 2008;248 773-781
Link to Journal
Our results corroborate those of other studies reporting a negative predictive value of more than 99% in masses at US with recognized benign characteristics, which allows greater confidence in the use of the Breast Imaging Reporting and Data System 3 category for US-determined probably benign masses, whether palpable or not, in a manner akin to the established mammographic paradigm
Sughra Raza, Sona A. Chikarmane, Sarah S. Neilsen, Lisa M. Zorn, and Robyn L. Birdwell
Radiology 2008;248 773-781
Link to Journal
Our results corroborate those of other studies reporting a negative predictive value of more than 99% in masses at US with recognized benign characteristics, which allows greater confidence in the use of the Breast Imaging Reporting and Data System 3 category for US-determined probably benign masses, whether palpable or not, in a manner akin to the established mammographic paradigm
Labels:
BIRADS,
BIRADS 3,
Indeterminate,
masses,
US
Subscribe to:
Posts (Atom)